Ekso Bionics (EKSO)

• Market cap: $12.1M
• 1 day: -2.18%
• 5 days: -3.81%
• 1 month: -13.36%
• 3 months: -23.83%
• 6 months: -39.72%
• Year to date: -11.90%
• 1 year: -69.87%
• 5 years: -90.36%
• 10 years: -99.07%
• Sector: Industrials
• Industry: General Industrial Machinery & Equipment, Not Elsewhere Classified

About: Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are EksoHealth and EksoWorks. All of the company's operations are held in the United States. The EksoHealth segment which derives majority revenue designs, engineers, manufactures and sells exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The regions company operates in are the Americas, EMEA, and APAC.

Employees: 72

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

133% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 3

17% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 6

14% more funds holding

Funds holding: 28 [Q3] → 32 (+4) [Q4]

6.44% less ownership

Funds ownership: 24.82% [Q3] → 18.37% (-6.44%) [Q4]

60% less capital invested

Capital invested by funds: $6.2M [Q3] → $2.47M (-$3.73M) [Q4]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $9 1,541% upside
• Avg. target: $9 1,541% upside
• High target: $9 1,541% upside

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

HC Wainwright & Co. Swayampakula Ramakanth 38% 1-year accuracy 74 / 194 met price target

1,541% upside $9

Buy Reiterated

14 Jan 2025